$EPZM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Epizyme, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Epizyme, Inc.. Get notifications about new insider transactions in Epizyme, Inc. for free.
Page: < prev 1 ... 2 3 4 5 6 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 30 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | A | 31.20 | 27,406 | 855,067 | 27,406 | |
Jan 30 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Option Exercise | A | 31.20 | 54,813 | 1,710,166 | 54,813 | |
Jan 15 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 39.86 | 2,266 | 90,319 | 25,931 | 28.2 K to 25.9 K (-8.04 %) |
Jan 15 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 38.86 | 3,286 | 127,697 | 28,197 | 31.5 K to 28.2 K (-10.44 %) |
Jan 15 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 39.86 | 3,858 | 153,773 | 44,090 | 47.9 K to 44.1 K (-8.05 %) |
Jan 15 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 38.86 | 5,596 | 217,465 | 47,948 | 53.5 K to 47.9 K (-10.45 %) |
Jan 06 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 0.51 | 14,000 | 7,140 | 312,459 | |
Jan 06 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Sell | S | 20.19 | 10,000 | 201,874 | 4,000 | 14 K to 4 K (-71.43 %) |
Jan 06 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 0.51 | 14,000 | 7,140 | 14,000 | 0 to 14 K |
Jan 06 2014 | EPZM | Epizyme, Inc. | Gould Robert J | President and CEO | Option Exercise | M | 0.51 | 3,334 | 1,700 | 867,223 | |
Jan 06 2014 | EPZM | Epizyme, Inc. | Gould Robert J | President and CEO | Option Exercise | M | 0.33 | 14,131 | 4,663 | 0 | |
Jan 06 2014 | EPZM | Epizyme, Inc. | Gould Robert J | President and CEO | Option Exercise | M | 0.30 | 12,535 | 3,761 | 0 | |
Jan 06 2014 | EPZM | Epizyme, Inc. | Gould Robert J | President and CEO | Sell | S | 20.18 | 3,334 | 67,295 | 0 | 3.3 K to 0 (-100.00 %) |
Jan 06 2014 | EPZM | Epizyme, Inc. | Gould Robert J | President and CEO | Buy | M | 0.51 | 3,334 | 1,700 | 3,334 | 0 to 3.3 K |
Jan 06 2014 | EPZM | Epizyme, Inc. | Gould Robert J | President and CEO | Sell | S | 20.16 | 14,131 | 284,829 | 0 | 14.1 K to 0 (-100.00 %) |
Jan 06 2014 | EPZM | Epizyme, Inc. | Gould Robert J | President and CEO | Buy | M | 0.33 | 14,131 | 4,663 | 14,131 | 0 to 14.1 K |
Jan 06 2014 | EPZM | Epizyme, Inc. | Gould Robert J | President and CEO | Sell | S | 20.16 | 12,535 | 252,654 | 0 | 12.5 K to 0 (-100.00 %) |
Jan 06 2014 | EPZM | Epizyme, Inc. | Gould Robert J | President and CEO | Buy | M | 0.30 | 12,535 | 3,761 | 12,535 | 0 to 12.5 K |
Dec 17 2013 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 2.19 | 4,600 | 10,074 | 49,810 | |
Dec 17 2013 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 21.21 | 4,600 | 97,545 | 53,544 | 58.1 K to 53.5 K (-7.91 %) |
Dec 17 2013 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 2.19 | 4,600 | 10,074 | 58,144 | 53.5 K to 58.1 K (+8.59 %) |
Dec 03 2013 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 20.70 | 1,850 | 38,288 | 31,483 | 33.3 K to 31.5 K (-5.55 %) |
Dec 03 2013 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 20.70 | 3,150 | 65,194 | 53,544 | 56.7 K to 53.5 K (-5.56 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | P | 19.31 | 25,800 | 498,185 | 406,500 | 380.7 K to 406.5 K (+6.78 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | P | 20.31 | 23,700 | 481,269 | 380,700 | 357 K to 380.7 K (+6.64 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | P | 19.04 | 163,620 | 3,115,538 | 357,000 | 193.4 K to 357 K (+84.61 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | P | 19.99 | 152,459 | 3,047,335 | 193,380 | 40.9 K to 193.4 K (+372.57 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | P | 20.91 | 40,921 | 855,654 | 40,921 | 0 to 40.9 K |
Nov 18 2013 | EPZM | Epizyme, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 19.31 | 25,800 | 498,185 | 406,500 | 380.7 K to 406.5 K (+6.78 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 20.31 | 23,700 | 481,269 | 380,700 | 357 K to 380.7 K (+6.64 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 19.04 | 163,620 | 3,115,538 | 357,000 | 193.4 K to 357 K (+84.61 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 19.99 | 152,459 | 3,047,335 | 193,380 | 40.9 K to 193.4 K (+372.57 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 20.91 | 40,921 | 855,654 | 40,921 | 0 to 40.9 K |
Nov 18 2013 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 19.31 | 25,800 | 498,185 | 406,500 | 380.7 K to 406.5 K (+6.78 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 20.31 | 23,700 | 481,269 | 380,700 | 357 K to 380.7 K (+6.64 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 19.04 | 163,620 | 3,115,538 | 357,000 | 193.4 K to 357 K (+84.61 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 19.99 | 152,459 | 3,047,335 | 193,380 | 40.9 K to 193.4 K (+372.57 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 20.91 | 40,921 | 855,654 | 40,921 | 0 to 40.9 K |
Nov 18 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 19.31 | 25,800 | 498,185 | 406,500 | 380.7 K to 406.5 K (+6.78 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 20.31 | 23,700 | 481,269 | 380,700 | 357 K to 380.7 K (+6.64 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 19.04 | 163,620 | 3,115,538 | 357,000 | 193.4 K to 357 K (+84.61 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 19.99 | 152,459 | 3,047,335 | 193,380 | 40.9 K to 193.4 K (+372.57 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 20.91 | 40,921 | 855,654 | 40,921 | 0 to 40.9 K |
Nov 18 2013 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | P | 19.31 | 25,800 | 498,185 | 406,500 | 380.7 K to 406.5 K (+6.78 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | P | 20.31 | 23,700 | 481,269 | 380,700 | 357 K to 380.7 K (+6.64 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | P | 19.04 | 163,620 | 3,115,538 | 357,000 | 193.4 K to 357 K (+84.61 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | P | 19.99 | 152,459 | 3,047,335 | 193,380 | 40.9 K to 193.4 K (+372.57 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | P | 20.91 | 40,921 | 855,654 | 40,921 | 0 to 40.9 K |
Nov 18 2013 | EPZM | Epizyme, Inc. | KERINS PATRICK J | 10% Owner | Buy | P | 19.31 | 25,800 | 498,185 | 406,500 | 380.7 K to 406.5 K (+6.78 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | KERINS PATRICK J | 10% Owner | Buy | P | 20.31 | 23,700 | 481,269 | 380,700 | 357 K to 380.7 K (+6.64 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | KERINS PATRICK J | 10% Owner | Buy | P | 19.04 | 163,620 | 3,115,538 | 357,000 | 193.4 K to 357 K (+84.61 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | KERINS PATRICK J | 10% Owner | Buy | P | 19.99 | 152,459 | 3,047,335 | 193,380 | 40.9 K to 193.4 K (+372.57 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | KERINS PATRICK J | 10% Owner | Buy | P | 20.91 | 40,921 | 855,654 | 40,921 | 0 to 40.9 K |
Nov 18 2013 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Buy | P | 19.31 | 25,800 | 498,185 | 406,500 | 380.7 K to 406.5 K (+6.78 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Buy | P | 20.31 | 23,700 | 481,269 | 380,700 | 357 K to 380.7 K (+6.64 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Buy | P | 19.04 | 163,620 | 3,115,538 | 357,000 | 193.4 K to 357 K (+84.61 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Buy | P | 19.99 | 152,459 | 3,047,335 | 193,380 | 40.9 K to 193.4 K (+372.57 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Buy | P | 20.91 | 40,921 | 855,654 | 40,921 | 0 to 40.9 K |
Nov 18 2013 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Buy | P | 19.31 | 25,800 | 498,185 | 406,500 | 380.7 K to 406.5 K (+6.78 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Buy | P | 20.31 | 23,700 | 481,269 | 380,700 | 357 K to 380.7 K (+6.64 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Buy | P | 19.04 | 163,620 | 3,115,538 | 357,000 | 193.4 K to 357 K (+84.61 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Buy | P | 19.99 | 152,459 | 3,047,335 | 193,380 | 40.9 K to 193.4 K (+372.57 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Buy | P | 20.91 | 40,921 | 855,654 | 40,921 | 0 to 40.9 K |
Nov 18 2013 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Buy | P | 19.31 | 25,800 | 498,185 | 406,500 | 380.7 K to 406.5 K (+6.78 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Buy | P | 20.31 | 23,700 | 481,269 | 380,700 | 357 K to 380.7 K (+6.64 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Buy | P | 19.04 | 163,620 | 3,115,538 | 357,000 | 193.4 K to 357 K (+84.61 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Buy | P | 19.99 | 152,459 | 3,047,335 | 193,380 | 40.9 K to 193.4 K (+372.57 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Buy | P | 20.91 | 40,921 | 855,654 | 40,921 | 0 to 40.9 K |
Nov 18 2013 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Buy | P | 19.31 | 25,800 | 498,185 | 406,500 | 380.7 K to 406.5 K (+6.78 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Buy | P | 20.31 | 23,700 | 481,269 | 380,700 | 357 K to 380.7 K (+6.64 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Buy | P | 19.04 | 163,620 | 3,115,538 | 357,000 | 193.4 K to 357 K (+84.61 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Buy | P | 19.99 | 152,459 | 3,047,335 | 193,380 | 40.9 K to 193.4 K (+372.57 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Buy | P | 20.91 | 40,921 | 855,654 | 40,921 | 0 to 40.9 K |
Nov 18 2013 | EPZM | Epizyme, Inc. | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Buy | P | 19.31 | 25,800 | 498,185 | 406,500 | 380.7 K to 406.5 K (+6.78 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Buy | P | 20.31 | 23,700 | 481,269 | 380,700 | 357 K to 380.7 K (+6.64 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Buy | P | 19.04 | 163,620 | 3,115,538 | 357,000 | 193.4 K to 357 K (+84.61 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Buy | P | 19.99 | 152,459 | 3,047,335 | 193,380 | 40.9 K to 193.4 K (+372.57 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Buy | P | 20.91 | 40,921 | 855,654 | 40,921 | 0 to 40.9 K |
Jul 03 2013 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | A | 29.95 | 50,000 | 1,497,500 | 50,000 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Option Exercise | A | 25.73 | 17,666 | 454,546 | 17,666 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Option Exercise | C | 0.00 | 195,904 | 0 | 0 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Option Exercise | C | 0.00 | 10,280,288 | 0 | 0 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Buy | P | 15.00 | 3,117 | 46,755 | 3,658,729 | 3.7 M to 3.7 M (+0.09 %) |
Jun 07 2013 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Buy | P | 15.00 | 163,549 | 2,453,235 | 3,655,612 | 3.5 M to 3.7 M (+4.68 %) |
Jun 07 2013 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Buy | C | 0.00 | 65,301 | 0 | 3,492,063 | 3.4 M to 3.5 M (+1.91 %) |
Jun 07 2013 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Buy | C | 0.00 | 3,426,762 | 0 | 3,426,762 | 0 to 3.4 M |
Jun 07 2013 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | A | 25.73 | 17,666 | 454,546 | 17,666 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | C | 0.00 | 195,904 | 0 | 0 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | C | 0.00 | 10,280,288 | 0 | 0 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 15.00 | 3,117 | 46,755 | 3,658,729 | 3.7 M to 3.7 M (+0.09 %) |
Jun 07 2013 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 15.00 | 163,549 | 2,453,235 | 3,655,612 | 3.5 M to 3.7 M (+4.68 %) |
Jun 07 2013 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Buy | C | 0.00 | 65,301 | 0 | 3,492,063 | 3.4 M to 3.5 M (+1.91 %) |
Jun 07 2013 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Buy | C | 0.00 | 3,426,762 | 0 | 3,426,762 | 0 to 3.4 M |
Jun 07 2013 | EPZM | Epizyme, Inc. | POPS RICHARD F | Director | Option Exercise | A | 25.73 | 17,666 | 454,546 | 17,666 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | KLEINER PERKINS CAUFIELD & BYE ... | 10% Owner | Option Exercise | C | 0.00 | 6,217,335 | 0 | 0 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | KLEINER PERKINS CAUFIELD & BYE ... | 10% Owner | Option Exercise | C | 0.00 | 6,462,918 | 0 | 0 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | KLEINER PERKINS CAUFIELD & BYE ... | 10% Owner | Buy | C | 0.00 | 2,072,445 | 0 | 4,226,751 | 2.2 M to 4.2 M (+96.20 %) |
Jun 07 2013 | EPZM | Epizyme, Inc. | KLEINER PERKINS CAUFIELD & BYE ... | 10% Owner | Buy | C | 0.00 | 2,154,306 | 0 | 2,154,306 | 0 to 2.2 M |
Jun 07 2013 | EPZM | Epizyme, Inc. | SEIDENBERG BETH C | Director | Option Exercise | A | 25.73 | 17,666 | 454,546 | 17,666 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | SEIDENBERG BETH C | Director | Option Exercise | C | 0.00 | 6,217,335 | 0 | 0 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | SEIDENBERG BETH C | Director | Option Exercise | C | 0.00 | 6,462,918 | 0 | 0 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | SEIDENBERG BETH C | Director | Buy | C | 0.00 | 2,072,445 | 0 | 4,226,751 | 2.2 M to 4.2 M (+96.20 %) |
Jun 07 2013 | EPZM | Epizyme, Inc. | SEIDENBERG BETH C | Director | Buy | C | 0.00 | 2,154,306 | 0 | 2,154,306 | 0 to 2.2 M |
Jun 07 2013 | EPZM | Epizyme, Inc. | KERINS PATRICK J | 10% Owner | Option Exercise | C | 0.00 | 16,899,721 | 0 | 0 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | KERINS PATRICK J | 10% Owner | Buy | P | 15.00 | 400,000 | 6,000,000 | 6,033,240 | 5.6 M to 6 M (+7.10 %) |
Jun 07 2013 | EPZM | Epizyme, Inc. | KERINS PATRICK J | 10% Owner | Buy | C | 0.00 | 5,633,240 | 0 | 5,633,240 | 0 to 5.6 M |
Jun 07 2013 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Option Exercise | C | 0.00 | 16,899,721 | 0 | 0 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Buy | P | 15.00 | 400,000 | 6,000,000 | 6,033,240 | 5.6 M to 6 M (+7.10 %) |
Jun 07 2013 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Buy | C | 0.00 | 5,633,240 | 0 | 5,633,240 | 0 to 5.6 M |
Jun 07 2013 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Option Exercise | C | 0.00 | 16,899,721 | 0 | 0 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | P | 15.00 | 400,000 | 6,000,000 | 6,033,240 | 5.6 M to 6 M (+7.10 %) |
Jun 07 2013 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | C | 0.00 | 5,633,240 | 0 | 5,633,240 | 0 to 5.6 M |
Jun 07 2013 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Option Exercise | C | 0.00 | 16,899,721 | 0 | 0 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Buy | P | 15.00 | 400,000 | 6,000,000 | 6,033,240 | 5.6 M to 6 M (+7.10 %) |
Jun 07 2013 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Buy | C | 0.00 | 5,633,240 | 0 | 5,633,240 | 0 to 5.6 M |
Jun 07 2013 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Option Exercise | C | 0.00 | 16,899,721 | 0 | 0 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Buy | P | 15.00 | 400,000 | 6,000,000 | 6,033,240 | 5.6 M to 6 M (+7.10 %) |
Jun 07 2013 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Buy | C | 0.00 | 5,633,240 | 0 | 5,633,240 | 0 to 5.6 M |
Jun 07 2013 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 16,899,721 | 0 | 0 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 15.00 | 400,000 | 6,000,000 | 6,033,240 | 5.6 M to 6 M (+7.10 %) |
Jun 07 2013 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 5,633,240 | 0 | 5,633,240 | 0 to 5.6 M |
Jun 07 2013 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 16,899,721 | 0 | 0 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Buy | P | 15.00 | 400,000 | 6,000,000 | 6,033,240 | 5.6 M to 6 M (+7.10 %) |
Jun 07 2013 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 5,633,240 | 0 | 5,633,240 | 0 to 5.6 M |
Jun 07 2013 | EPZM | Epizyme, Inc. | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 16,899,721 | 0 | 0 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 15.00 | 400,000 | 6,000,000 | 6,033,240 | 5.6 M to 6 M (+7.10 %) |
Jun 07 2013 | EPZM | Epizyme, Inc. | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 5,633,240 | 0 | 5,633,240 | 0 to 5.6 M |
Jun 07 2013 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Option Exercise | C | 0.00 | 16,899,721 | 0 | 0 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | P | 15.00 | 400,000 | 6,000,000 | 6,033,240 | 5.6 M to 6 M (+7.10 %) |
Jun 07 2013 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | C | 0.00 | 5,633,240 | 0 | 5,633,240 | 0 to 5.6 M |
Jun 07 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | A | 25.73 | 17,666 | 454,546 | 17,666 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | C | 0.00 | 16,899,721 | 0 | 0 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 15.00 | 400,000 | 6,000,000 | 6,033,240 | 5.6 M to 6 M (+7.10 %) |
Jun 07 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | C | 0.00 | 5,633,240 | 0 | 5,633,240 | 0 to 5.6 M |
Jun 07 2013 | EPZM | Epizyme, Inc. | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | C | 0.00 | 16,899,721 | 0 | 0 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Buy | P | 15.00 | 400,000 | 6,000,000 | 6,033,240 | 5.6 M to 6 M (+7.10 %) |
Jun 07 2013 | EPZM | Epizyme, Inc. | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Buy | C | 0.00 | 5,633,240 | 0 | 5,633,240 | 0 to 5.6 M |
Jun 06 2013 | EPZM | Epizyme, Inc. | Shiosaki Kazumi | Director | Option Exercise | A | 25.73 | 17,666 | 454,546 | 17,666 | |
Jun 06 2013 | EPZM | Epizyme, Inc. | MPM BioVentures IV QP LP | 10% Owner | Option Exercise | C | 0.00 | 1,176,472 | 0 | 0 | |
Jun 06 2013 | EPZM | Epizyme, Inc. | MPM BioVentures IV QP LP | 10% Owner | Option Exercise | C | 0.00 | 6,930,000 | 0 | 0 | |
Jun 06 2013 | EPZM | Epizyme, Inc. | MPM BioVentures IV QP LP | 10% Owner | Buy | C | 0.00 | 392,156 | 0 | 2,880,485 | 2.5 M to 2.9 M (+15.76 %) |
Jun 06 2013 | EPZM | Epizyme, Inc. | MPM BioVentures IV QP LP | 10% Owner | Buy | C | 0.00 | 2,309,998 | 0 | 2,488,329 | 178.3 K to 2.5 M (+1,295.34 %) |
Jun 06 2013 | EPZM | Epizyme, Inc. | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 1,176,472 | 0 | 0 | |
Jun 06 2013 | EPZM | Epizyme, Inc. | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 6,930,000 | 0 | 0 | |
Jun 06 2013 | EPZM | Epizyme, Inc. | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 392,156 | 0 | 2,880,485 | 2.5 M to 2.9 M (+15.76 %) |
Jun 06 2013 | EPZM | Epizyme, Inc. | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 2,309,998 | 0 | 2,488,329 | 178.3 K to 2.5 M (+1,295.34 %) |
Jun 06 2013 | EPZM | Epizyme, Inc. | Celgene European Investment Co ... | 10% Owner | Option Exercise | C | 0.00 | 9,803,922 | 0 | 0 | |
Jun 06 2013 | EPZM | Epizyme, Inc. | Celgene European Investment Co ... | 10% Owner | Buy | P | 15.00 | 66,666 | 999,990 | 3,334,640 | 3.3 M to 3.3 M (+2.04 %) |
Jun 06 2013 | EPZM | Epizyme, Inc. | Celgene European Investment Co ... | 10% Owner | Buy | C | 0.00 | 3,267,974 | 0 | 3,267,974 | 0 to 3.3 M |
Jun 06 2013 | EPZM | Epizyme, Inc. | Astellas Venture Fund I L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,904,762 | 0 | 0 |